Ascendis Pharma A/S

SecurityASND / Ascendis Pharma A/S
InstitutionGhost Tree Capital, LLC
Latest Disclosed Ownership52,500 shares
Latest Disclosed Value $ 7,838,775
Ghost Tree Capital, LLC ownership in ASND / Ascendis Pharma A/S

On November 14, 2024 - Ghost Tree Capital, LLC filed a 13F-HR form disclosing ownership of 52,500 shares of Ascendis Pharma A/S (US:ASND) valued at $7,838,775 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 14, 2024 disclosing 86,721 shares of Ascendis Pharma A/S. This represents a change in shares of -39.46% during the quarter. The current value of the position is $11,381,475 USD.

Ghost Tree Capital, LLC has a history of taking positions in derivatives of the underlying security (ASND) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ASND / Ascendis Pharma A/S Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-11-14 2024-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 52,500 -34,221 -39.46 7,839 -33.73 2.3679
2024-08-14 2024-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 86,721 86,721 11,827 3.7036
2024-05-15 2024-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 0 -20,000 -100.00 0 -100.00
2024-02-14 2023-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 20,000 -65,000 -76.47 2,519 -68.35 0.8236
2023-11-14 2023-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 85,000 -15,000 -15.00 7,959 -10.82 2.6177
2023-08-14 2023-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 100,000 -10,000 -9.09 8,925 -24.33 2.9463
2023-05-15 2023-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 110,000 -20,000 -15.38 11,794 -25.72 3.4860
2023-02-14 2022-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 130,000 35,000 36.84 15,877 61.85 6.7786
2022-11-14 2022-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 95,000 20,000 26.67 9,810 40.71 2.7536
2022-08-15 2022-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 75,000 -65,000 -46.43 6,972 -57.57 3.6314
2022-05-16 2022-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 140,000 -50,000 -26.32 16,430 -35.72 3.5655
2022-02-16 2021-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 190,000 70,000 58.33 25,561 33.64 9.1603
2021-11-15 2021-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 120,000 -15,000 -11.11 19,127 7.70 5.5929
2021-08-11 2021-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 135,000 0 0.00 17,759 2.07 4.8817
2021-08-11 2021-03-31 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 135,000 30,000 28.57 17,399 -0.65 4.0893
2021-05-14 2021-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 135,000 30,000 17,399 4.0893
2021-02-18 2020-12-31 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 105,000 -25,000 -19.23 17,512 -12.71 3.9022
2021-02-16 2020-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 105,000 -25,000 17,512 3,808,960.3661
2020-11-16 2020-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 130,000 65,000 100.00 20,062 108.67 5.7985
2020-08-14 2020-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 65,000 -85,000 -56.67 9,614 -43.09 2.5365
2020-05-15 2020-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 150,000 -50,000 -25.00 16,892 -39.29 4.4802
2020-04-09 2019-12-31 13F/A-2 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 200,000 50,000 33.33 27,824 92.58 5.2986
2020-02-14 2019-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 200,000 50,000 27,824 5,263,526.2826
2020-04-09 2019-09-30 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 150,000 -75,000 -33.33 14,448 -44.24 3.6810
2019-11-14 2019-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 150,000 -75,000 14,448 3,670,312.0832
2020-04-09 2019-06-30 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 225,000 -160,000 -41.56 25,909 -42.82 5.3738
2019-08-14 2019-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 225,000 -160,000 25,909 5,426,127.6770
2020-04-09 2019-03-31 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 385,000 260,000 208.00 45,315 478.66 11.8390
2019-05-15 2019-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 385,000 260,000 45,315 12,277,060.8746
2020-04-09 2018-12-31 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 125,000 -100,000 -44.44 7,831 -50.88 2.8420
2019-02-14 2018-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 125,000 -100,000 7,831 2,746,890.4120
2020-04-09 2018-09-30 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 225,000 50,000 28.57 15,944 36.96 3.3890
2018-11-14 2018-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 225,000 50,000 15,944 3,396,358.2451
2018-08-14 2018-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 175,000 35,000 25.00 11,641 27.14 3.4259
2018-05-15 2018-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 140,000 -110,000 -44.00 9,156 -8.58 1.8524
2018-02-14 2017-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 250,000 50,000 25.00 10,015 38.14 2.3485
2017-11-14 2017-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 200,000 200,000 7,250 1.5396
2016-11-14 2016-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 0 -100,000 -100.00 0 -100.00
2016-08-12 2016-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 100,000 100,000 0.00 1,327 0.3832
2016-02-17 2015-12-31 13F/A-1 ASCENDIS PHARMA A S SPONDSORED ADR 04351P101 0 -97,135 -100.00 0 -100.00
2015-11-16 2015-09-30 13F ASCENDIS PHARMA A ADR 04351P101 97,135 33,396 52.39 1,719 52.53 0.7736
2015-09-09 2015-06-30 13F/A-1 ASCENDIS PHARMA A S SPONDSORED ADR 04351P101 63,739 63,739 1,127 0.3652
2015-08-14 2015-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 63,739 1,127 0.3896
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-04-09 2019-06-30 13F/A ASCENDIS PHARMA A S SPONSORED ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-04-09 2019-03-31 13F/A ASCENDIS PHARMA A S SPONSORED ADR Put 185,000 21,775 n/a n/a n/a
2019-05-15 2019-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR Put 185,000 9,250 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.